Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
- Award ceiling
- up to $2,200,000
- Closes
- Sep 30, 2026
- Last verified
- 2026-10-18
Awards up to $2,200,000 per recipient for others (see text field entitled "additional information on eligibility" for clarification), closing Sep 30, 2026.
In one sentence
Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed) awards up to $2,200,000 per recipient, open to others (see text field entitled "additional information on eligibility" for clarification), closing Sep 30, 2026.
- Program pool (total)
- $3,300,000Total across all awards in this programme. Not an amount any single applicant can receive.
- Award ceiling (per project)
- $2,200,000
- Award floor
- Not confirmed
- Typical award
- Not confirmed
- Deadline
- Sep 30, 2026
- Deadline type
- Fixed date
- Opens
- May 20, 2026
- Status
- Closed
- Eligible entities
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Geography
- Not stated
- Matching funds
- No
- Disbursement
- Not confirmed
- Application effort
- Not confirmed
- Use of funds
- diabetes research · islet distribution · development of new therapies for the prevention and treatment of diabetes
- Currency
- USD
How much money is available?
Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.
Who can apply?
Not confirmed
Source field: applicant size limitOnly the PI/PDs associated with the award issued under RFA-DK-20-509 to Beckman Research Institute/City of Hope is eligible to apply for this single source funding. Refer to Section III. Eligibility Information in the NOFO for additional…
We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.When does it close?
What can the money be used for?
3 categorysThe source’s own spending categories, and what is not parsed.
These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.
How hard is the application?
1 fieldEffort, match requirement and reimbursement, as the source stated them.
- Application effort
- Not confirmed
- Disbursement
- Not confirmed
- Matching funds
- No
What comparable notices state
291 recordsStated ceilings on open records in the same industry.
Among open records stored under Health & Human Services, 291 of 889 state an award ceiling. Those that do run:
- 25th percentile$357,500
- Median$600,000
- 75th percentile$1,500,000
A statistical estimate, not a prediction. It describes what a set of notices has published in this catalogue on the day you read it, and says nothing about what this programme will award. Records stating no ceiling are excluded rather than counted as zero, and the programme pool — what a funder has across every applicant — is a different column and is never mixed in.
Who has won this programme before?
9106 awardsAwards under the same assistance listing, not under this notice.
9106 federal awards on file under assistance listing 93.847, the programme this notice is published under. These are not awards made under this notice — a listing covers every year the programme runs, and awards under an open notice do not exist yet.
- $440,444,754BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASONWA · FY2014
- $200,221,259RHO FEDERAL SYSTEMS DIVISION INCNC · FY2015
- $181,279,494UNIVERSITY OF SOUTH FLORIDAFL · FY2015
- $112,529,392GEORGE WASHINGTON UNIVERSITY (THE)MD · FY2001
- $82,457,560THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKNY · FY2022
Common questions
6 questionsEvery answer is a stored field from this record. Questions the source did not answer are not asked.
- How much can one applicant receive?
- Up to $2,200,000 per recipient.
- How much funding is available in total?
- $3,300,000 across the whole programme. This is the total the funder has allocated, not an amount any single applicant can receive.
- When is the application deadline?
- Sep 30, 2026.
- Who is eligible to apply?
- Others (see text field entitled "Additional Information on Eligibility" for clarification).
- What can the funding be used for?
- diabetes research, islet distribution, development of new therapies for the prevention and treatment of diabetes, as classified by the source.
- Is matching funding required?
- No. The source states that no matching funds are required.
AI summary of the source text
Optional. Every core field on this record is already above, free and complete.
AI summary of the source text
Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.
Included with Studio
Sign inWhat else is open
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)Closes Nov 13, 2026Awards up to $1,050,000
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)Closes Nov 13, 2026Awards up to $350,000
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)Closes Nov 17, 2026Awards Not stated
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)Closes Nov 19, 2026Awards Not stated
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)Closes Dec 3, 2026Awards Not stated
- Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)Closes Jan 7, 2027Awards up to $250,000
A listing names the programme; a notice names one round of it. These are other rounds open now, not other years of this one.
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)Closes Not statedAwards Not stated
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)Closes Nov 17, 2026Awards Not stated
- The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)Closes Not statedAwards Not stated
- The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)Closes Not statedAwards Not stated
- The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating CenterCloses Not statedAwards Not stated
- The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research CentersCloses Not statedAwards Not stated
The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.